Center for Medical Ethics and Health Policy Staff Publications
Language
English
Publication Date
7-16-2024
Journal
Cell Reports Medicine
DOI
10.1016/j.xcrm.2024.101628
PMID
38986621
PMCID
PMC11293353
PubMedCentral® Posted Date
7-16-2024
PubMedCentral® Full Text Version
Post-print
Abstract
Chimeric antigen receptor T cells (CART) targeting lymphocyte antigens can induce T cell fratricide and require additional engineering to mitigate self-damage. We demonstrate that the expression of a chimeric antigen receptor (CAR) targeting CD5, a prominent pan-T cell antigen, induces rapid internalization and complete loss of the CD5 protein on T cells, protecting them from self-targeting. Notably, exposure of healthy and malignant T cells to CD5.CART cells induces similar internalization of CD5 on target cells, transiently shielding them from cytotoxicity. However, this protection is short-lived, as sustained activity of CD5.CART cells in patients with T cell malignancies results in full ablation of CD5
Keywords
CD5 Antigens, Humans, Receptors, Chimeric Antigen, Cytotoxicity, Immunologic, T-Lymphocytes, Immunotherapy, Adoptive, Animals, Receptors, Antigen, T-Cell
Published Open-Access
yes
Recommended Citation
Ma, Royce; Woods, Mae; Burkhardt, Phillip; et al., "Chimeric Antigen Receptor-Induced Antigen Loss Protects CD5.CART Cells From Fratricide Without Compromising On-Target Cytotoxicity" (2024). Center for Medical Ethics and Health Policy Staff Publications. 74.
https://digitalcommons.library.tmc.edu/med_ethics/74